Elżbieta Wyska

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Pharmacokinetic/Pharmacodynamic Assessment of Selective Phosphodiesterase Inhibitors in a Mouse Model of Autoimmune Hepatitis”.

Pharmacokinetic/Pharmacodynamic Assessment of Selective Phosphodiesterase Inhibitors in a Mouse Model of Autoimmune Hepatitis

Journal of Pharmacology and Experimental Therapeutics(2022)10.1124/jpet.121.001004

N/A

0DataRank · unranked

6 citations

Bartosz Pomierny, Elżbieta Wyska, William J. Jusko, Artur Świerczek

KM-408, a novel phenoxyalkyl derivative as a potential anticonvulsant and analgesic compound for the treatment of neuropathic pain

Pharmacological Reports(2022)10.1007/s43440-022-00431-7

N/A

0DataRank · unranked

1 citations

Henryk Marona, Katarzyna Pańczyk, Barbara Filipek, Anna Rapacz, Kinga Sałat +14 more

Targeting Neuroinflammation and Cognitive Decline: First-in-Class Dual Butyrylcholinesterase and p38α Mitogen-Activated Protein Kinase Inhibitors

Journal of Medicinal Chemistry(2025)10.1021/acs.jmedchem.5c00933

N/A

0DataRank · unranked

4 citations

Matic Proj, Damijan Knez, Urban Košak, A. Meden, Katja Krajšek +23 more